Thrombose coronaire très tardive par fracture du stent actif. Cas clinique et revue de la littérature

Van Werkum, 2009, Long-term clinical outcome after a first angiographically confirmed coronary stent thrombosis: an analysis of 431 cases, Circulation, 119, 828, 10.1161/CIRCULATIONAHA.108.799403 Armstrong, 2012, Clinical presentation, management, and outcomes of angiographically documented early, late, and very late stent thrombosis, JACC Cardiovasc Interv, 5, 131, 10.1016/j.jcin.2011.10.013 Cutlip, 2007, Clinical end points in coronary stent trials: a case for standardized definitions, Circulation, 115, 2344, 10.1161/CIRCULATIONAHA.106.685313 Mboup, 2013, Very late bare-metal stent thrombosis 10 years after the implantation: a case report, Ann Cardiol Angeiol (Paris), 62, 435, 10.1016/j.ancard.2012.04.005 Daneault, 2014, Acute left main coronary occlusion caused by stent fracture. Peri-stent aneurysm formation, and very late stent thrombosis: revisiting the dark side of drug-eluting stents, Can J Cardiol, 30, 146e1, 10.1016/j.cjca.2013.07.677 Aoki, 2007, Incidence and clinical impact of coronary stent fracture after sirolimus stent implantation, Catheter Cardiovasc Interv, 69, 380, 10.1002/ccd.20950 Lee, 2007, Stent fracture associated with drug eluting stents: clinical characteristics and implications, Catheter Cardiovasc Interv, 69, 387, 10.1002/ccd.20942 Tae-Hyung, 2009, Clinical characteristics of stent fracture after sirolimus-eluting stent implantation, Int J Cardiol, 131, 212, 10.1016/j.ijcard.2007.10.059 Brodie, 2011, Very late stent thrombosis after primary percutaneous coronary intervention with bare-metal and drug-eluting stents for ST-segment elevation myocardial infarction. A 15-year single-center experience, JACC Cardiovasc Interv, 4, 30, 10.1016/j.jcin.2010.11.004 Rahman, 2008, Very late sirolimus eluting stent displaced fracture in the mid left anterior descending artery, J Invasive Cardiol, 20, 195 Chung, 2008, The incidence and clinical impact of stent strut fractures developed after drug-eluting stent implantation, Int J Cardiol, 125, 325, 10.1016/j.ijcard.2007.02.033 Yamada, 2008, Serial angiographic and intravascular ultrasound analysis of late stent strut fracture of sirolimus eluting stents in native coronary arteries, Int J Cardiol, 130, 255, 10.1016/j.ijcard.2007.08.082 Kim, 2009, Incidence and predictors of drug-eluting fractures in long coronary disease, Int J Cardiol, 133, 354, 10.1016/j.ijcard.2008.01.005 Dorsh, 2006, Stent fracture and collapse in a saphenous vein graphs causing occlusive restenosis, J Invasive Cardiol, 18, 37 Shite, 2006, Sirolimus eluting stent fracture with thrombus, visualization by optical coherence tomography, Eur Heart J, 27, 1389, 10.1093/eurheartj/ehi542 Sianos, 2004, Stent fracture and restenosis in the drug eluting stent era, Catheter Cardiovasc Interv, 61, 111, 10.1002/ccd.10709 Ben Salem, 2012, Sirolimus-eluting stent displaced fracture: case report and review of the literature, Ann Cardiol Angeiol (Paris), 61, 64, 10.1016/j.ancard.2011.04.003 Nagm Eldin, 2011, Very delayed coronary stent fracture: a case report, J Saudi Heart Assoc, 23, 249, 10.1016/j.jsha.2011.05.006 Dudek, 2011, Four-year clinical follow-up of the ABSORB everolimus-eluting bioresorbable vascular scaffold in patients with de novo coronary artery disease: the ABSORB trial, EuroIntervention, 7, 1060, 10.4244/EIJV7I9A168 Serruys, 2011, Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical and imaging outcomes, J Am Coll Cardiol, 58, 1578, 10.1016/j.jacc.2011.05.050